Oncology & Cancer

DNA nanotubes deliver therapeutics to glioblastoma tumors

Glioblastoma is widely considered the most aggressive brain cancer. Even with treatment, patient survival rates are low, with most living an average of 15–18 months after diagnosis. Because of the highly diverse characteristics ...

Oncology & Cancer

Talk between immune cells could lead to new cancer vaccine

In the past decade, immunotherapy has helped save the lives of many cancer patients, many with lung cancer, who might have otherwise faced almost certain death sentences. However, only about 20% of patients who received immune ...

page 16 from 40